What is Perspective Therapeutics's change in AP?

Perspective Therapeutics (CATX) reported change in AP of -$4.21M in Q1 2026.

How has Perspective Therapeutics's change in AP changed year-over-year?

Perspective Therapeutics's change in AP decreased by 146.2% year-over-year, from -$1.71M to -$4.21M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Perspective Therapeutics CATX Change in AP

Change in AP at other companies

Eli LillyLLY

$2.55B+290%

CytomX TherapeuticsCTMX

$67K+108%

Monopar TherapeuticsMNPR

-$287.14K+62.8%

ImmunomeIMNM

$1.42M+137%

Viridian Therapeutics, Inc.VRDN

$4.63M+162%

Lantheus HoldingsLNTH

$190K-96.2%

Other financials

Income statement

See full

Revenue$2.2M+27.3%

Gross profit$738.0K+78.3%

Operating income-$28.3M-29.5%

Net income-$26.2M-44.1%

EPS (diluted)-$0.250.0%

Balance sheet

See full

Cash & equivalents$54.0M+21.5%

Total debt$4.2M+10.9%

Total equity$347.4M+22.1%

Total assets$410.8M+24.7%

Cash flow

See full

Operating cash flow-$31.5M-45.8%

CapEx$6.9M+47.3%

Free cash flow-$38.3M-46.1%

Valuation

See full

Market cap$342.14M+33.2%

Enterprise value$292.34M+35.2%

P/S34.2×+19.6×

Profitability

See full

Gross margin33.1%-7.1pp

Operating margin-292.7%-553pp

Net margin-218.4%-781pp

FCF margin-1,073.3%—

Returns & leverage

See full

Return on equity-35.2%+2.3pp

Debt / equity0×0.0×

Current ratio8.7×-8.3×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Perspective Therapeutics's change in AP?: Perspective Therapeutics (CATX) reported change in AP of -$4.21M in Q1 2026.
How has Perspective Therapeutics's change in AP changed year-over-year?: Perspective Therapeutics's change in AP decreased by 146.2% year-over-year, from -$1.71M to -$4.21M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.